HIT Consultant October 28, 2024
Rob Juncker, CTO of Code42 (now part of Mimecast)

It’s said that data is the lifeblood of the modern enterprise. While that’s certainly true, it’s also true that there is perhaps no industry as dependent on data – and protecting it – as the life sciences sector.

Of course, the very nature of data has evolved significantly over the past few years. What once consisted of straightforward records and research results has now expanded to include highly complex and distributed datasets generated by advanced technologies like genomics, AI-driven predictive models, and comprehensive and digitized patient histories. This data is not only critical for the day-to-day operations and strategic decisions of life sciences companies, but also holds immense potential for future breakthroughs in treatments and therapies.

The stakes couldn’t...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
OpenAI Roundup: Happenings In The End Of An AI Year
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Healthcare providers will need to boost cyber defenses amid AI adoption: Moody’s
Breaking Through The Generative AI Memory Wall
Google Cloud launches AI Agent Space amid rising competition

Share This Article